Cost-effectiveness of dual-energy X-ray absorptiometry plus antiresorptive treatment in Australian women with breast cancer who receive aromatase inhibitors
Postmenopausal women with breast cancer on aromatase inhibitor (AI) treatment are at increased risk of bone mineral density loss, which may lead to minimal trauma fractures. We examined the cost-effectiveness of dual energy X-ray absorptiometry (DXA) with antiresorptive (AR) therapy compared with fracture risk assessment, lifestyle advice, and vitamin supplementation. We used a hypothetical Markov cohort model of lifetime duration for 60-year-old women with early stage breast cancer receiving...[Show more]
|Collections||ANU Research Publications|
|Source:||Journal of Bone and Mineral Metabolism|
|01_Sowa_Cost-effectiveness_of_2017.pdf||1.88 MB||Adobe PDF|
Request a copy
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.